Statin use linked to reduced risk of hepatocellular cancer

February 12, 2013
Statin use linked to reduced risk of hepatocellular cancer
Statin use is associated with a reduced risk of hepatocellular carcinoma, most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

(HealthDay)—Statin use is associated with a reduced risk of hepatocellular carcinoma (HCC), most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

Siddharth Singh, M.B.B.S., from the Mayo Clinic in Rochester, Minn., and colleagues conducted a systematic literature review and meta-analysis of studies that evaluated the effects of statins on the risk of HCC. The analysis included 10 studies reporting 4,298 cases of HCC in 1,459,417 patients.

The researchers found that, compared with statin nonusers, statin users were significantly less likely to develop HCC (adjusted odds ratio [aOR], 0.63), although there was considerable heterogeneity in the results (P = 0.01; I² = 59 percent). Suggested sources of this heterogeneity included study location (Asian population [four studies]: aOR, 0.52; Western population [six studies]: aOR, 0.67) and study design ( [seven studies]: aOR, 0.60; clinical trials [three studies]: aOR, 0.95; 95 percent confidence interval, 0.62 to 1.45).

"In summary, our meta-analysis suggests that use of statins is associated with a reduced risk of HCC," the authors write. "However, these results should be interpreted with caution given the possibility of residual confounding. Future randomized clinical trials or prospective cohort studies in populations at high risk for HCC (especially in the Asian -infected population) are warranted."

Explore further: If the diabetes has a direct carcinogenetic effect?

More information: Abstract
Full Text

Related Stories

If the diabetes has a direct carcinogenetic effect?

October 29, 2008

The association of DM2 with solid tumors, and particularly with HCC, has been long suspected and several studies have reported increased mortality rates for neoplastic diseases in patients with DM2. However, the temporal ...

Study indicates cancer preventive effect for statins

May 5, 2009

The commonly used prescription statin drugs may have a protective effect in the prevention of liver cancer and lead to a reduction in the need for gallbladder removals, according to two studies published in Gastroenterology. ...

Hepatitis B virus mutations may predict risk of liver cancer

July 2, 2009

Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a ...

Incidence of recurrent anal sphincter rupture is 7.1 percent

October 26, 2012

(HealthDay)—The incidence of recurrent anal sphincter rupture (ASR) is 7.1 percent, and several risk factors are associated with an increased risk, including excessive birth weight, vacuum extraction, and shoulder dystocia, ...

Recommended for you

Molecularly shutting down cancer cachexia

August 30, 2016

Healthy fat tissue is essential for extended survival in the event of tumor-induced wasting syndrome (cachexia). In Nature Medicine, researchers at Helmholtz Zentrum München show that selective manipulation of an enzyme ...

Radiologists detect breast cancer in 'blink of an eye'

August 29, 2016

A new study by investigators at Brigham and Women's Hospital in collaboration with researchers at the University of York and Leeds in the UK and MD Andersen Cancer Center in Texas puts to the test anecdotes about experienced ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.